CClinicalTrials.gg
CompletedNCT04444180Updated Jan 23, 2023

The Predictive Role of Self-representation in Transition of Individuals at Clinical High Risk for Psychosis

An observational study in Clinical High Risk for Psychosis, sponsored by Shanghai Mental Health Center. Completed at 1 site in China. Open to participants aged 11 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-01-23.

Sponsored by Shanghai Mental Health Center · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
160
Ages
11 Years to 45 Years
Sex
All
01

Study summary

Schizophrenia is one of the most consumptive diseases, which brings great loss to patients and their families, and even to the society. Clinical High Risk for Psychosis (CHR) is a concept put forward on the basis of the prodromal stage of schizophrenia. Over the past 20 years, the identification and intervention of CHR has become the focus of psychiatric research, with the primary goal of early identification of biomarkers of susceptibility to schizophrenia and the development of individualized interventions to prevent or delay progression. Longitudinal studies have shown that CHR converted to schizophrenia mainly within two years, with a risk of about 30 percent. Self-disorder is one of the core characteristics of schizophrenia. The two most basic experiences of self-representation are sense of ownership and sense of agency. Sense of ownership refers to the sense that "I" perceives "my" body, while sense of agency refers to the sense that "I" experiences "my" actions and their consequences are initiated by "me". Some studies have shown that patients with schizophrenia show defects in the sense of ownership and agency. The most commonly used paradigm for observing "sense of ownership" and "sense of agency" is the rubber hand illusion (RHI) or the virtual hand illusion (VHI). In this study, the VHI experimental paradigm will be used to detect the self-representation of the individuals at high risk for psychosis, and the clinical outcome will be observed for one year.The hypothesis is that the subjects who exhibit abnormal illusion experience in VHI experiment are more likely to transition into psychotic disorders.

Read the detailed description

This study is conducted according to the tenets of the Declaration of Helsinki. All participants are recruited at the Shanghai Mental Health Center (SMHC) or its affiliate, the Shanghai Psychotherapy and Psychological Counseling Center (SPCC) with written informed consent, approved by the Research Ethics Committee of SMHC. For those younger than 18 years, both the adolescents and their next of kin or legal guardians are provided informed consents. The outpatients are recommended by doctors to participate in our CHR screening. After being screened and interviewed, those who meet the inclusion criteria are informed and signed written informed consent. Once the subjects are recruited, clinical evaluation, VHI and MCCB test will be conducted. In addition, CHR individuals will be followed up at one-year node.

02

Conditions studied

  • Clinical High Risk for Psychosis

Keywords

  • sense of ownership
  • sense of agency
  • virtual hand illusion
03

In context

Psychotic Disorders

1,626 studies on the registry are indexed under Psychotic Disorders; 293 are open to participants now.

This study's enrollment of 160 is close to the median of 150 across 245 observational studies indexed under Psychotic Disorders.

Browse Psychotic Disorders studies →

Lead sponsor

Shanghai Mental Health Center is the lead sponsor of 267 studies on the registry; 93 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
11 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

This study mainly observe the behavioral representation and its predictive role in transition outcome of CHR individuals, who meeting the criteria of psychosis-risk syndromes (COPS) for the existence of one or more of psychosis high risk syndromes, such as brief intermittent psychotic syndrome (BIPS), attenuated positive symptom syndrome (APSS), and genetic risk and deterioration syndrome (DRDS).

Inclusion criteria

  • For CHR individuals, meet the criteria of psychosis-risk syndromes after rating by structured interview for psychosis high risk syndrome.
  • For FES patients, meet diagnostic criteria for schizophrenia in the DSM-IV.
  • For HC individuals, gender composition, age range, educational level are matched with CHR individuals.
  • Understand and sign written informed consent.

Exclusion criteria

Exclusion Criteria:

  • For CHR individuals, exclude individuals with other axis I or II mental disorders, which can explain the abnormal experience.
  • For CHR and FES patients, exclude those patients taking antipsychotics for more than two weeks.
  • For HC individuals, exclude those with family history of mental disorders
  • With a history of substance dependence.
  • Use of medications that may affect mental and cognitive functions.
  • With central nervous system disorder, that cuase symptoms or interfere with judgment.
  • Traumatic brain injury score is 7 or more.
  • With serious or unstable physical diseases.
  • With perceptual developmental disorders.
  • IQ\<70.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
160 participants (actual)
Target follow-up
1 Year
Patient registry
Yes

Groups and cohorts

  • Clinical high risk for psychosis (CHR)

    No intervention. Just use virtual hand illusion (VHI) paradigm to observe the outcome of individuals with CHR at one-year follow-up node and analyze the predictive role of self-representation in transition into psychosis.

    Diagnostic Test: Virtual hand illusion (VHI)

  • First episode of schizophrenia (FES)

    In contrast to FES, it is anticipated to observe CHR individuals with similar behavioral performance to FES may presented higher risk of transition.

    Diagnostic Test: Virtual hand illusion (VHI)

  • Healthy control (HC)

    In contrast to HC, it is anticipated to observe CHR individuals with similar behavioral performance to HC may presented lower risk of transition.

    Diagnostic Test: Virtual hand illusion (VHI)

Interventions

  • Diagnostic testVirtual hand illusion (VHI)

    Using VHI, the two basic self-representation of sense of ownership and sense of agency of the subjects will be observed.

06

What researchers measure

Primary outcomes

  1. Behavioral indicators

    To compare the behavioral performance in VHI experimental paradigm among the three groups of CHR, FES, and HC

    Time frame: Baseline

  2. Predictive indicators

    To analyze the predictive role of self-representation in transition of CHR into psychosis

    Time frame: One-year follow-up node

Secondary outcomes

  1. Resting-state brain functional connectivity (FC)

    To observe the relationship of the behavioral performance in VHI experimental paradigm with the Resting-state brain functional connectivity

    Time frame: Baseline

  2. Event-related potential technique

    To observe the relationship of the behavioral performance in VHI experimental paradigm with the error-related negativity

    Time frame: Baseline

  3. Neurocognitive function

    To observe the relationship of the behavioral performance in VHI experimental paradigm with the neurocognitive functions

    Time frame: Baseline

  4. Other predictive indicators

    To analyze the predictive role of FC and neurocognitive functions related to self-representation in transition of CHR into psychosis

    Time frame: One-year follow-up node

07

Study locations

1 site
  • Shanghai Mental Health Center
    Shanghai, Shanghai 200030, China
08

References and documents

Publications

  • Raballo A, Monducci E, Ferrara M, Fiori Nastro P, Dario C; RODIN group. Developmental vulnerability to psychosis: Selective aggregation of basic self-disturbance in early onset schizophrenia. Schizophr Res. 2018 Nov;201:367-372. doi: 10.1016/j.schres.2018.05.012. Epub 2018 May 25. PubMed 29804931 ↗
  • Ebisch SJH, Aleman A. The fragmented self: imbalance between intrinsic and extrinsic self-networks in psychotic disorders. Lancet Psychiatry. 2016 Aug;3(8):784-790. doi: 10.1016/S2215-0366(16)00045-6. Epub 2016 Jun 30. PubMed 27374147 ↗
  • Newen A, Vogeley K. Self-representation: searching for a neural signature of self-consciousness. Conscious Cogn. 2003 Dec;12(4):529-43. doi: 10.1016/s1053-8100(03)00080-1. PubMed 14656496 ↗
  • Synofzik M, Vosgerau G, Newen A. I move, therefore I am: a new theoretical framework to investigate agency and ownership. Conscious Cogn. 2008 Jun;17(2):411-24. doi: 10.1016/j.concog.2008.03.008. Epub 2008 Apr 14. PubMed 18411059 ↗
  • Shaqiri A, Roinishvili M, Kaliuzhna M, Favrod O, Chkonia E, Herzog MH, Blanke O, Salomon R. Rethinking Body Ownership in Schizophrenia: Experimental and Meta-analytical Approaches Show no Evidence for Deficits. Schizophr Bull. 2018 Apr 6;44(3):643-652. doi: 10.1093/schbul/sbx098. PubMed 29036731 ↗
  • Germine L, Benson TL, Cohen F, Hooker CI. Psychosis-proneness and the rubber hand illusion of body ownership. Psychiatry Res. 2013 May 15;207(1-2):45-52. doi: 10.1016/j.psychres.2012.11.022. Epub 2012 Dec 28. PubMed 23273611 ↗
  • Fusar-Poli P, Cappucciati M, Borgwardt S, Woods SW, Addington J, Nelson B, Nieman DH, Stahl DR, Rutigliano G, Riecher-Rossler A, Simon AE, Mizuno M, Lee TY, Kwon JS, Lam MM, Perez J, Keri S, Amminger P, Metzler S, Kawohl W, Rossler W, Lee J, Labad J, Ziermans T, An SK, Liu CC, Woodberry KA, Braham A, Corcoran C, McGorry P, Yung AR, McGuire PK. Heterogeneity of Psychosis Risk Within Individuals at Clinical High Risk: A Meta-analytical Stratification. JAMA Psychiatry. 2016 Feb;73(2):113-20. doi: 10.1001/jamapsychiatry.2015.2324. PubMed 26719911 ↗

Individual participant data

Plan to share: Undecided

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 23, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04444180
Lead sponsor
Shanghai Mental Health Center
Responsible party
Sponsor
First posted
Jun 23, 2020
Start date
Jul 6, 2019
Primary completion
Nov 30, 2021
Completion
Nov 30, 2021
Last update
Jan 23, 2023

Study contacts

Jijun Wang, Doctoral
study chair · Shanghai Mental Health Center
Tianhong Zhang, Doctoral
study director · Shanghai Mental Health Center

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion